Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results

IRVINE, Calif., May 4, 2012 /PRNewswire/ -- PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for its fiscal third quarter and nine months ended March 31, 2012.

(Logo: http://photos.prnewswire.com/prnh/20111025/LA93174LOGO-c)

Pro-Dex, Inc. (the "Company") reported a loss from continuing operations of $513,000, or $0.16 per diluted share, for the quarter ended March 31, 2012 compared to income from continuing operations of $909,000, or $0.28 per diluted share, in the same period of fiscal 2011.  The net loss for the third quarter of fiscal 2012 was $487,000 or $0.15 per diluted share, compared to net income of $868,000 or $0.26 per diluted share in the third quarter of fiscal 2011.  Sales for the quarter ended March 31, 2012 decreased 34% to $4.5 million from $6.9 million for the corresponding quarter in 2011, and decreased 21% to $13.6 million from $17.3 million for the nine months ended March 31, 2012 and 2011, respectively.  For the nine months ended March 31, 2012, the net loss was $332,000, or $0.10 per diluted share, as compared to net income of $1.6 million, or $0.49 per diluted share for the corresponding period in 2011.  As the Company has disclosed previously, the decrease in sales and the resulting net losses were primarily the result of the continuation of a reduction in purchases of the Company's medical device products by its largest customer. The results from continuing operations for the 2012 and 2011 periods exclude the results of the Company's former Astromec product line, which was sold in February 2012 as previously announced. 

Gross profit for the quarter ended March 31, 2012 was $1.2 million, or 27%, compared to gross profit of $2.8 million, or 41%, for the year-ago period.  For the nine months ended March 31, 2012 gross profit was $4.6 million, or 34%, compared to $7.2 million and 42%, respectively, for the corresponding nine-month period in 2011. These decreases resulted primarily from the year-over-year decrease in sales and a commensurate change in sales mix to products with lower gross margins. Also contributing to the 2012 gross margin decreases in the three-month period were reductions in manufacturing efficiencies due to the lower sales volume. In addition, higher warranty expenses contributed to the decreased gross margin in the 2012 nine-month period due to higher estimated per-unit repair costs for units that remain under warranty.

As previously announced by the Company, Mark P. Murphy, formerly the Company's Chief Executive Officer and a director, resigned all of his positions with the Company and its subsidiary on April 20, 2012. Under the terms of the Separation Agreement entered into with Mr. Murphy, the Company agreed to pay him severance and to continue health insurance coverage for a period of one year, the aggregate cost of which was $339,000 and which was included in general and administrative expenses during the quarter ended March 31, 2012.  The Company also entered into a six month consulting agreement with Mr. Murphy at a cost of $5,000 per month.

Operating expenses, which include selling, general and administrative, and research and development expenses, for the third fiscal quarter of 2012 increased 20% to $1,875,000 from $1,568,000 in the prior year's quarter.  The increase was primarily attributable to the payment of the severance costs associated with the previously noted change in chief executive officers and $58,000 of trade show and advertising expenses which were partially offset by reductions in employee related costs of $125,000.   For the nine months ended March 31, 2012, operating expenses increased from the prior year's nine month period by $330,000, or 7%.  This increase was generally due to the previously noted severance costs in the third quarter of 2012, increases in advertising, trade show and travel expenses of $168,000, increased spending for small motor development of $65,000, and share-based compensation expense of $44,000, which were partially offset by reductions in website costs of $121,000 and employee related costs of $232,000.

The pre-tax loss from continuing operations was $680,000 for the quarter, compared to income from continuing operations of $1.2 million in the corresponding 2011 period.   

Michael J. Berthelot, the Company's President and Chief Executive Officer, commented, "I would like to thank Mark for all he has done for Pro-Dex over the past six years.  He has left us with a strong balance sheet, a growing portfolio of new and under-development products, a solid management team and a top rate work force."

"Our Company is at a transition point," Mr. Berthelot continued, "We have a host of opportunities to pursue, but we must do so with care and excellence in execution.  We have identified several initiatives which we believe will help us focus our resources on those actions that will provide significant and sustainable returns over both the short and long term.  As we move forward we plan to emphasize the effectiveness of our sales process; our ability to exceed customer expectations for development and delivery; our commitment to innovation and quality; and, to constantly assess our cost structure."

"I am very excited and proud to be part of Pro-Dex's leadership team.  We have a lot of hard work to do and a tight schedule within which to accomplish it, but I have confidence that our associates at every level are up to the challenge of providing sustainable value to our customers, our people and our shareholders."

Teleconference Information:

Investors and analysts are invited to listen to a broadcast review of the Company's fiscal 2012 third quarter financial results today at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) that may be accessed by visiting the Company's website at www.pro-dex.com.  The conference call may also be accessed at www.InvestorCalendar.com. Investors and analysts who would like to participate in the conference call may do so via telephone at (877) 407-8033, or at (201) 689-8033 if calling from outside the U.S. or Canada.

For those who cannot access the live broadcast, a replay will be available approximately two hours after the completion of the call until midnight (Eastern Time) on May 22, 2012 by calling (877) 660-6853, or (201) 612-7415 if calling from outside the U.S. or Canada, and then entering account number 286 and conference I.D. number 393235.  An online archive of the broadcast will be available on the Company's website www.pro-dex.com for a period of 365 days.

Pro-Dex, Inc., with operations in California and Oregon, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate powered surgical device drive and embedded motion control systems serving the medical, dental, semi-conductor and scientific research markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities and high tech manufacturing operations around the world. For more information, visit the Company's website at www.pro-dex.com.

          Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.

(tables follow)

PRO-DEX, INC. and SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)




March 31, 2012


June 30, 2011

ASSETS



Current assets:



Cash and cash equivalents

$

4,879,000

$

4,689,000

Accounts receivable, net of allowance for doubtful accounts of $13,000 at March 31, 
               2012 and $7,000 at June 30, 2011

2,228,000

 

3,128,000

Other receivables

88,000

 

12,000

Inventories

3,059,000

 

3,703,000

Prepaid expenses

193,000

145,000

Income taxes receivable

407,000

--

Deferred income taxes


162,000


163,000




Total current assets

11,016,000

11,840,000

Property, plant, equipment and leasehold improvements, net

2,597,000

3,661,000

Real estate held for sale

733,000

--

Other assets


54,000


60,000




Total assets

$

14,400,000


$

15,561,000




LIABILITIES AND SHAREHOLDERS' EQUITY



Current liabilities:



Accounts payable

$

1,029,000

$

1,207,000

Accrued expenses

1,995,000

2,379,000

Income taxes payable

--

78,000

Current portion of bank term loan


357,000


357,000




Total current liabilities


3,381,000


4,021,000




Non-current liabilities:



Bank term loan

506,000

774,000

Deferred income taxes

162,000

163,000

Deferred rent


286,000


279,000




Total non-current liabilities


954,000


1,216,000




Total liabilities


4,335,000


5,237,000




Commitments and contingencies



Shareholders' equity:



Common shares; no par value; 50,000,000 shares authorized; 3,272,350 shares issued and outstanding at March 31, 2012 and at June 30, 2011

16,817,000

16,744,000

Accumulated deficit


(6,752,000)


(6,420,000)




Total shareholders' equity


10,065,000


10,324,000




Total liabilities and shareholders' equity

$

14,400,000


$

15,561,000




 

PRO-DEX, INC. and SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)




For The Three Months

Ended March 31,



2012


2011

Net sales

$

4,539,000

$

6,876,000

Cost of sales


3,336,000


4,082,000




Gross profit


1,203,000


2,794,000







Operating expenses:



Selling expenses

450,000

422,000

General and administrative expenses

939,000

675,000

Research and development costs


486,000


471,000




Total operating expenses


1,875,000


1,568,000




Income (loss) from continuing operations before items below


(672,000)


1,226,000







Other expense:



Interest expense, net


(8,000)


(55,000)




Total other expense


(8,000)


(55,000)




Income (loss) from continuing operations before provision for income taxes

(680,000)

1,171,000




Provision for (benefit from) income taxes


(167,000)


262,000




Income (loss) from continuing operations

(513,000)

909,000




Income (loss) from discontinued operations


26,000


(41,000)







Net income (loss

$

(487,000)


$

868,000




Net income (loss) per share:



Basic

$

(0.15)

$

0.27

Diluted

$

(0.15)

$

0.26

Weighted average shares outstanding — basic

3,272,350

3,272,350

Weighted average shares outstanding — diluted

3,272,350

3,289,324

PRO-DEX, INC. and SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)



For the Nine Months Ended
March 31,



2012


2011

Net sales

$

13,601,000

$

17,314,000

Cost of sales


9,043,000


10,092,000




Gross profit


4,558,000


7,222,000







Operating expenses:



Selling expenses

1,192,000

1,197,000

General and administrative expenses

2,375,000

2,205,000

Research and development costs


1,555,000


1,390,000




Total operating expenses


5,122,000


4,792,000




Income from operations


(564,000)


2,430,000







Other income (expense):



Interest expense, net


(28,000)


(135,000)




Total other income (expense


(28,000)


(135,000)




Income (loss) from continuing operations before items below

(592,000)

2,295,000




Provision for (benefit from) income taxes


(165,000)


426,000




Income (loss) from continuing operations

(427,000)

$

1,869,000




Income (loss) from discontinued operations


95,000


(258,000)

Net income (loss

$

(332,000)


$

1,611,000




Net income (loss) per share:



Basic

$

(0.10)

$

0.49

Diluted

$

(0.10)

$

0.49

Weighted average shares outstanding — basic

3,272,350

3,262,474

Weighted average shares outstanding — diluted

3,272,350

3,270,549

 

PRO-DEX, INC. and SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)



For The Nine Months Ended

March 31,



2012


2011

Cash flows from operating activities:



Net income (loss

$

(332,000)

$

1,611,000

Adjustments to reconcile net income (loss) to net cash used in operating activities:



Depreciation and amortization

493,000

508,000

Allowance for doubtful accounts

7,000

(17,000)

Share-based compensation

73,000

28,000

Changes in:



Accounts receivable

817,000

(415,000)

Inventories

644,000

(188,000)

Prepaid expenses

(48,000)

(56,000)

Other assets

8,000

17,000

Accounts payable and accrued expenses

(555,000)

166,000

Income taxes payable


(486,000)


158,000




Net cash provided by (used in) operating activities


621,000


1,812,000




Cash flows from investing activities:



Purchases of equipment and leasehold improvements

(245,000)

(181,000)

Proceeds from sale of equipment


82,000


--




Net cash used in investing activities


(163,000)


(181,000)




Cash flows from financing activities:



Principal payments on term loan

(268,000)

(296,000)

Net proceeds from bank term loan refinancing

--

150,000

Principal payments on mortgage

--

(1,528,000)

Proceeds from exercise of stock options


--


27,000




Net cash used in financing activities


(268,000)


(1,647,000)




Net increase (decrease) in cash and cash equivalents

190,000

(16,000)

Cash and cash equivalents, beginning of period


4,689,000


3,794,000




Cash and cash equivalents, end of period

$

4,879,000


$

3,778,000


Supplemental Information

Cash payments for interest

$

25,000

$

151,000




Cash payments for income taxes

$

54,000

$

205,000

SOURCE Pro-Dex, Inc.



RELATED LINKS
http://www.pro-dex.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.